Item | Progestin-primed ovarian stimulation group | GnRH-antagonist group | Microstimulation group | Z/x2 value | P value |
---|---|---|---|---|---|
No. of cases | 38 | 27 | 24 | Â | Â |
Female age(year) | 33.34 ± 4.14 | 32.30 ± 3.83 | 34.13 ± 4.50 | 1.331 | 0.270 |
Male age (year) | 35.21 ± 7.88 | 33.11 ± 3.11 | 34.67 ± 4.92 | 0.990 | 0.376 |
Female body mass index( kg/m2) | 22.93 ± 2.81 | 23.76 ± 3.11 | 23.81 ± 2.92 | 0.920 | 0.402 |
Duration of infertility (year) | 4.01 ± 3.58 | 4.41 ± 3.15 | 2.99 ± 2.87 | 1.226 | 0.299 |
Antral follicle count | 6.16 ± 2.46 | 11.30 ± 6.72bc | 6.50 ± 3.43 | 12.008 | P < 0.001 |
Basal follicle stimulating hormone (IU/L) | 9.69 ± 5.02 | 8.20 ± 3.02 | 10.23 ± 4.35 | 1.565 | 0.215 |
Basal luteinizing hormone (IU/L) | 12.91 ± 42.90 | 4.73 ± 2.09 | 4.55 ± 2.28 | 0.936 | 0.396 |
Main etiology of infertility (%) | |||||
 Tubal factor | 52.6 (20/38) | 44.4 (12/27) | 70.8 (17/24) | 4.623 | 0.099 |
 Diminished ovarian reserve | 73.7 (28/38) | 66.7 (18/27) | 54.1 (13/24) | 1.913 | 0.384 |
 Male factor | 26.3 (10/38) | 22.2 (6/27) | 16.1 (4/24) | 0.655 | 0.721 |
 Other factors | 57.8 (22/38) | 62.9 (17/27) | 70.8 (17/24) | 1.596 | 0.450 |
 Starting dosage of Gn | 286.32 ± 72.12a | 230.56 ± 65.63 | 265.63 ± 49.35 | 4.088 | 0.020 |
 Dosage of Gn used | 2806.58 ± 747.25 | 2467.11 ± 755.83 | 2818.75 ± 742.44 | 2.013 | 0.140 |
 Endometrial thickness on HCG injection day | 8.03 ± 1.74 | 10.50 ± 2.29bc | 6.93 ± 1.83 | 23.053 | P < 0.001 |